Literature DB >> 9730682

Expression of chemokines RANTES, MIP-1alpha and GRO-alpha correlates with inflammation in acute experimental autoimmune encephalomyelitis.

A R Glabinski1, V K Tuohy, R M Ransohoff.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) is an investigator-initiated disorder that serves as an animal model for the common human demyelinating disease multiple sclerosis. Both diseases are typified by disseminated perivascular and submeningeal cuffs in the central nervous system (CNS). It was shown recently that chemokines are integral to the pathogenesis of EAE. In the present study we analyzed the gene expression of three chemokines, RANTES, MIP-1alpha and GRO-alpha, at the onset of acute EAE, and correlated that expression with the intensity of inflammatory changes in the CNS. We showed that all three chemokines are upregulated simultaneously with symptom onset of acute EAE, and that chemokine expression correlates with the intensity of inflammation in the CNS. This consistent relationship supports the hypothesis that chemokines are relevant to leukocyte accumulation in CNS parenchyma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9730682     DOI: 10.1159/000026333

Source DB:  PubMed          Journal:  Neuroimmunomodulation        ISSN: 1021-7401            Impact factor:   2.492


  28 in total

Review 1.  Chemokines and central nervous system disorders.

Authors:  W J Karpus
Journal:  J Neurovirol       Date:  2001-12       Impact factor: 2.643

Review 2.  Regulation of experimental autoimmune encephalomyelitis by chemokines and chemokine receptors.

Authors:  Adam Elhofy; Kevin J Kennedy; Brian T Fife; William J Karpus
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 3.  G protein-coupled receptors as therapeutic targets for multiple sclerosis.

Authors:  Changsheng Du; Xin Xie
Journal:  Cell Res       Date:  2012-06-05       Impact factor: 25.617

4.  Androgens suppress antigen-specific T cell responses and IFN-γ production during intracranial LCMV infection.

Authors:  Adora A Lin; Sara E Wojciechowski; David A Hildeman
Journal:  J Neuroimmunol       Date:  2010-09-14       Impact factor: 3.478

5.  Gamma interferon signaling in macrophage lineage cells regulates central nervous system inflammation and chemokine production.

Authors:  Adora A Lin; Pulak K Tripathi; Allyson Sholl; Michael B Jordan; David A Hildeman
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

6.  Chronic exposure to the chemokine CCL3 enhances neuronal network activity in rat hippocampal cultures.

Authors:  M Kuijpers; K L I van Gassen; P N E de Graan; D Gruol
Journal:  J Neuroimmunol       Date:  2010-08-01       Impact factor: 3.478

Review 7.  Chemokine receptor CXCR2: physiology regulator and neuroinflammation controller?

Authors:  Mike Veenstra; Richard M Ransohoff
Journal:  J Neuroimmunol       Date:  2012-03-22       Impact factor: 3.478

8.  Th1 cytokines stimulate RANTES chemokine secretion by human astroglial cells depending on de novo transcription.

Authors:  Q Q Li; C T Bever
Journal:  Neurochem Res       Date:  2001-02       Impact factor: 3.996

9.  A potential role of the GRO-α/CXCR2 system in Sjögren's syndrome: regulatory effects of pro-inflammatory cytokines.

Authors:  Sabrina Lisi; Margherita Sisto; Dario Domenico Lofrumento; Massimo D'Amore; Raffaella De Lucro; Domenico Ribatti
Journal:  Histochem Cell Biol       Date:  2012-10-05       Impact factor: 4.304

10.  IL-1R signaling within the central nervous system regulates CXCL12 expression at the blood-brain barrier and disease severity during experimental autoimmune encephalomyelitis.

Authors:  Erin E McCandless; Matthew Budde; Jason R Lees; Denise Dorsey; Eric Lyng; Robyn S Klein
Journal:  J Immunol       Date:  2009-06-17       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.